Boehringer Ingelheim, Lilly expand heart failure program for Jardiance with new clinical trials

This article was originally published here

Boehringer Ingelheim and Eli Lilly have unveiled plans to expand their clinical trial program for Jardiance in chronic heart failure with the EMPERIAL clinical trials.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply